AnaSpec Introduces Industry’s First Anti-MOG ELISA Assay Kits

San Jose, CA, September 10, 2011 --(PR.com)-- AnaSpec is pleased to be the first in the industry to provide Anti-MOG (Myelin Oligodendrocyte Glycoprotein) ELISA assay kits. The SensoLyte® Anti-Human MOG (1-125) IgG Quantitation ELISA Kit, SensoLyte® Anti-Mouse MOG (1-125) and SensoLyte® Anti-Rat MOG (1-125) IgG ELISA assay kits are useful for determining the amount of anti-human MOG (1-125), anti-mouse MOG (1-125) and anti-rat MOG (1-125) antibodies, respectively.

The SensoLyte® Anti-MOG (35-55) IgG Quantitative ELISA kit is optimized to detect anti-MOG (35-55) mouse/rat IgG. Using strips pre-coated with MOG (35-55) peptide and pre-blocked with BSA, the amount of anti-MOG IgG in serum or cerebrospinal fluid can be determined by ELISA. Absorbance is read at 450 nm.

For more information, please visit https://www.anaspec.com/products/promotions.asp?col=1&row=1

AnaSpec, EGT Group
AnaSpec, EGT Group is a leading provider of integrated proteomics and genomics solutionsTM for worldwide life science research. AnaSpec offers expertise in peptides, detection reagents, antibodies, assay kits, amino acids, oligonucleotides, and qPCRs. AnaSpec carries a broad product line of biochemicals and reagents for basic research, high-throughput screening and drug discovery. AnaSpec also provides premier custom services including peptide synthesis, antibody production, assay development, fluorescent dyes, and oligonucleotide synthesis. AnaSpec is certified to ISO 9001:2008.

For more information visit www.anaspec.com

###